Insulet (NASDAQ:PODD) released second-quarter financial results and hosted an earnings call on Wedne

Barclays analyst Christopher Pasquale initiates coverage on Insulet (NASDAQ:PODD) with a Equal-We

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and lowers

Leerink Partners analyst Mike Kratky downgrades Insulet (NASDAQ:PODD) from Outperform to Market P

TD Cowen analyst Mathew Blackman maintains Insulet (NASDAQ:PODD) with a Hold and lowers the price

UBS analyst Patrick Wood maintains Insulet (NASDAQ:PODD) with a Neutral and lowers the price targ

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

Benchmark analyst Bruce D. Jackson maintains Insulet (NASDAQ:PODD) with a Buy and lowers the pric

Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price tar

Analysts changed outlook on top names: JP Morgan cut price target for Insulet, HC Wainwright slashed

Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. HUBS

Insulet Corp. (NASDAQ:PODD) reported strong Q2 earnings but lowered revenue outlook for 2021. Analy

Wells Fargo analyst Lawrence Biegelsen downgrades Insulet (NASDAQ:PODD) from Overweight to Equal-

JP Morgan analyst Robbie Marcus downgrades Insulet (NASDAQ:PODD) from Overweight to Neutral and l

Truist Securities analyst Richard Newitter downgrades Insulet (NASDAQ:PODD) from Buy to Hold and

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday&#39

Insulet (PODD) stock falls despite beating Q2 earnings as the company lowers its full-year 2026 reve

Insulet (NASDAQ:PODD) FY2026 expected to be more than $6.46 vs $6.43 Est. lowers FY2026 sales outlo

Insulet (NASDAQ:PODD) reported quarterly earnings of $1.66 per share which beat the analyst consensu

The partnership introduces The Mind in Range Collection, a set of tailored mindfulness resources ava

Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price tar

Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and raises the pr

FDA classified Insulet's Omnipod pod recall as Class I after reports of insulin under-delivery l

Evercore ISI Group analyst Daniel Markowitz maintains Insulet (NASDAQ:PODD) with a Outperform and

Spain is the 26th country where Insulet sells Omnipod, and the 20th country where Omnipod 5 is avail

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo

Deutsche Bank analyst Kieran Ryan initiates coverage on Insulet (NASDAQ:PODD) with a Buy rating a

Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers

STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across ag

U.S. tech stocks plunged more than 3% by midday Friday after a hotter-than-expected jobs report fuel

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-insulin-pump

Presentations will feature next generation Omnipod innovations designed to reduce user effort, new a

Enhanced algorithm with new 100 mg/dL Target Glucose and improved alarm handling helps users improve

Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and lowers the pr

Dow notches fresh all-time high while Nasdaq 100 drops 0.7% as chip stocks unwind. Oil sinks nearly

RBC Capital analyst Shagun Singh reiterates Insulet (NASDAQ:PODD) with a Outperform and maintains

Stock futures rise on Wednesday, with Verra Mobility's shares plunging 45% after Avis Budget Gro

Wall Street analysts changed outlook on top stocks. Check analyst ratings page for all changes, inc

BTIG analyst Marie Thibault maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price targe

Insulet Corporation, Inc. (NASDAQ:PODD) ("Insulet" or the "Company") today announced

B of A Securities analyst Travis Steed maintains Insulet (NASDAQ:PODD) with a Buy and lowers the

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.

Morgan Stanley downgraded FCX and Raymond James downgraded IRDM, while MoffettNathanson downgraded D